Hui Huitong 100-person VIP Buyers Group Meeting with API CHINA

On November 16th, 2016, Sinopharm Reed Exhibitions and Beijing Huisongtong Information Technology Co., Ltd. held a large-scale supply and demand meeting to meet in the same period. Relying on the powerful buyer database and rich industry resources of Beijing Huisongtong Technology, the company collects the actual needs of users and combines the powerful appeal of API CHINA to build a trading platform for both parties.

On the morning of the 16th, two bus buses of the Hui Huitong Group in Beijing slowly stopped at the entrance of the Wuhan International Expo Center. The team members of the buyers on board the car were fully loaded with the event. Under the guidance of the guide card, uniforms were bought and bought. Family group costumes gather at the entrance of the exhibition center.

At 9 o'clock, with the official opening of the exhibition, Hui Huitong buyers delegation entered the exhibition hall through an exclusive channel specially opened by the organizers.

Before the tour began, the organizer collected the purchase intention of the buyer group, and formulated a diversified and refined line for this demand. In addition to covering major purchases, the content also covers the highlights and new points of the exhibition. Some exhibitors with new products and new technologies are also included in the tour route of the buyer group.

Hui Huitong's buyer group at the peak of the entrance to the Expo only enjoyed "evading congestion"

The arrival of the buyer's group aroused much attention in the exhibition hall

Promote the integration of the pharmaceutical industry

The official of the organizer, Beijing Huisongtong Information Technology Co., Ltd., said, “In addition to the daily information matching service, we hope that the supply and demand sides can negotiate with what they see, hear, and touch. We adopted this In this way, the buyers and sellers match each other through our unique internal operations, and provide a series of pre-trade understandings for the parties to meet, negotiate, conduct field visits, etc., in order to effectively change the ecological environment of the pharmaceutical industry.”

2016 was a year in which the Chinese pharmaceutical industry entered a deep adjustment. Affected by the ongoing policy reforms such as the two-vote system, flight inspection, consistency assessment and price pressure, although the performance of some companies rebounded, the overall industry performance continued. Weak. The overall revenue of the pharmaceutical industry increased by 10% in the first half of 2016, slightly improving compared to 9.1% for the full year of 2015. Under the new opportunities and challenges, API CHINA has sincerely cooperated with Hui Huitong Buyer Group and gathered with pharmaceutical colleagues in Wuhan. Heli is the development of the pharmaceutical industry in China, especially with the implementation of the two-vote system for pharmaceuticals and consistency assessment, which will play a positive role in fully promoting the upstream and downstream integration of pharmaceutical companies.